Snapshot from Nov 22, 2026 at 07:00 UTC. For live data and tracking: View Live
Business earnings schedule

Teva Sets Q3 2026 Earnings Call Date

Analysis based on 7 articles · First reported Sep 23, 2026 · Last updated Sep 23, 2026

Sentiment
0
Attention
1
Articles
7
Market Impact
General
Live prominence charts, article sentiment distribution, and event development timeline available on the Ergen Dashboard

This is a routine scheduling announcement with no financial figures or guidance, so it should have minimal immediate impact on Teva's share price or the broader pharmaceutical sector. Any meaningful market reaction will wait for the actual third quarter results and management commentary on November 3, 2026.

pharmaceuticals

Sun Pharma announced on September 23, 2026 that it will release its third quarter 2026 financial results on Tuesday, November 3, 2026 at 7:00 a.m. ET. The company will follow the release with a conference call and live webcast at 8:00 a.m. ET the same day. A replay of the webcast will be available on Teva's investor relations website within 24 hours after the call concludes. The announcement is a routine scheduling notice and contains no preliminary financial figures, guidance, or operational updates. Teva shares trade on the New York Stock Exchange and the Ghana Stock Exchange under the ticker TEVA. The company describes itself as transforming into a leading innovative biopharmaceutical company supported by a world-class generics business, with focus areas including neuroscience, immunology, complex generics, biosimilars, and pharmacy brands. The notice also includes standard forward-looking statement language referencing risks related to competition, execution of the Pivot to Growth strategy, indebtedness, compliance and litigation matters, and general financial and economic conditions. No market-moving information was disclosed in the announcement itself; investor attention will center on the November 3 release and call.

60 Sun Pharma announced earnings release date
stock
Teva is the sole subject of the announcement, scheduling its Q3 2026 earnings release and conference call for November 3, 2026. The notice itself is neutral for the company's valuation, with investor focus deferred to the actual results.
Importance 100.0 Sentiment 0.0
exch
Teva's shares are listed on the New York Stock Exchange under the ticker TEVA, making it the venue where the earnings release will be reflected in trading. The scheduling announcement has no direct effect on the exchange.
Importance 10.0 Sentiment 0.0
exch
Teva's shares also trade on the Ghana Stock Exchange, where the November 3 earnings release will be reflected in local trading. The announcement itself has no direct effect on the exchange.
Importance 10.0 Sentiment 0.0
ERGEN INTELLIGENCE
Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.